Skip to content

A Wyss Center spin-off specializing in brain monitoring and neurostimulation

Charting a new course for brain disorder management, care and discovery

BrainScape Medical is developing an end-to-end solution to solve the many problems of current brain disorder management and care. The start-up aims to advance and scale intensive monitoring and personalized care, and spur new discoveries in brain science using innovative technology and data analytics. The company offers brain monitoring options designed for easy, patient-friendly, and long-term use outside the clinic.

A small device for endless possibilities

In 2025, The Wyss Center granted BrainScape Medical an exclusive license for Epios®, a cutting-edge device designed for continuous, long-term brain activity monitoring. Epios® offers a minimally invasive solution for diagnosing and treating neurological disorders, with first-in-human trials demonstrating promising results. Developed during seven years at the Wyss Center, Epios® provides full-head subscalp EEG monitoring using minimally invasive electrodes, allowing for continuous brain activity recording. This is critical for managing conditions such as epilepsy and dementia. This system uniquely integrates both monitoring and neuromodulation, enabling real-time therapeutic interventions.

Minimally invasive, Maximally informative

With state of the art monitoring, BrainScape Medical is building next levels in care; neurofeedback and neurostimulation for personalized therapies.

Epios®

 

A configurable 7-32 channel, subscalp EEG system inserted using Epios® tools.

Wearable device

The external headpiece magnetically couples to the subscalp transceiver, providing power and data transfer functions for the EEG.

Data visualization

The system comes with Epios® Cloud software for EEG data visualisation, annotation and reporting.

Analytics

 

BrainScape will be offering data analytics, reports and insight discoveries as a future service.

“The Epios technology represents a significant advancement in neurotechnology. Our goal is to bring this innovative solution to patients worldwide, improving their experience managing and living with their neurological disorder through better diagnosis and treatment.”

 

Laura Johnson

CEO, BrainScape Medical

“We are thrilled to see Epios® progressing toward clinical application. Our partnership with BrainScape Medical reflects our commitment to advancing impactful neurotechnologies that have market impact and directly benefit patients.”

 

Dr. Erwin Böttinger

Director of The Wyss Center

https://wysscenter.ch/wp-content/uploads/brainscape-banner.png

More information

Visit BrainScape Medical’s website to learn more about their work.